Kiniksa Pharmaceuticals Announces Development Indication for AbiprubartGlobe Newswire • about 2 months agoAbiprubart Phase 2b trial in Sjogren's Disease planned to initiate in 2H 2024 Abiprubart Phase 2 Cohort 4 rheumatoid arthritis data further validate biological activity Abiprubart development...